Rezeal Biotech Private Limited
About Rezeal Biotech Private Limited
Data last updated:
Rezeal Biotech Private Limited is a private limited company based in Pratapgarh, Uttar Pradesh, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 23 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24304UP2016PTC084296. Its GSTIN is 09AAHCR8062P1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rehana Begum and Akhtar Husain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 558 A Sadar Bazar Road, Pratapgarh, Uttar Pradesh, India – 230001.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.51 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net loss of ₹33,957 (net margin -1.7%) and EBITDA of -₹29,868 (EBITDA margin -1.5%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rezeal Biotech Private Limited's registered office is in Pratapgarh, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address558 A Sadar Bazar Road, Pratapgarh, Uttar Pradesh, India – 230001
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Rezeal Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rezeal Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Rezeal Biotech Private Limited, buy the company report.
Financials of Rezeal Biotech Private Limited
FY 2025 filings availableRezeal Biotech Private Limited reported revenue of ₹19.51 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 11% fall in the latest year. EBITDA fell 516% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹29,868 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹33,957 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.5% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rezeal Biotech Private Limited, buy the company report.
Board of directors of Rezeal Biotech Private Limited
Rezeal Biotech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rehana Begum | Director | 23 Jun 2016 | 10 Years 4 Months | Current |
| Akhtar Husain | Director | 23 Jun 2016 | 10 Years 4 Months | Current |
| Seema | Director | 23 Jun 2016 | 10 Years 4 Months | Current |
Peer comparison
Rezeal Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parchoon Desi Products Private Limited | ₹19.53 Lakh (FY 2024) | Lucknow, Uttar Pradesh, India | ||||
| DFB Pharma Private Limited | ₹19.52 Lakh (FY 2024) | -8.0% | Delhi, India | |||
| Mahavir Seamless Tube Private Limited | ₹19.52 Lakh (FY 2025) | -82.0% | Mumbai, Maharashtra, India | |||
| Mercyking Pharmaceuticals Private Limited | ₹19.52 Lakh (FY 2024) | -22.0% | Panvel, Maharashtra, India | |||
| Innov Api Private Limited | ₹19.51 Lakh (FY 2024) | -57.0% | Delhi, India | |||
| Rezeal Biotech Private Limitedthis company | ₹19.51 Lakh (FY 2024) | -₹33,957 | -1.7% | -11.0% | Pratapgarh, Uttar Pradesh, India | |
| Care and Cure Formulations Private Limited | ₹19.51 Lakh (FY 2019) | -23.0% | Chennai, Tamil Nadu, India | |||
| Accrete Innovations Private Limited | ₹19.51 Lakh (FY 2025) | 43.0% | Jaipur, Rajasthan, India | |||
| Airific Systems Private Limited | ₹19.51 Lakh (FY 2025) | -86.0% | Delhi, India | |||
| Cimbs Associates Private Limited (OPC) | ₹19.51 Lakh (FY 2025) | -27.0% | Delhi, India | |||
| Hetika Medical & Surgicals Private Limited | ₹19.51 Lakh (FY 2024) | -61.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Rezeal Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rezeal Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rezeal Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rezeal Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCR8062P1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rezeal Biotech Private Limited, buy the company report.
Recent activity
Rezeal Biotech Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Akhtar Husain was appointed as Director on 23 Jun 2016.
Frequently asked questions
Rezeal Biotech is an active private limited company based in Pratapgarh, Uttar Pradesh, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 23 June 2016 (10+ years old) and is registered under CIN U24304UP2016PTC084296.
Rezeal Biotech has 3 current directors:
- Rehana Begum - Director
- Akhtar Husain - Director
- Seema - Director
The latest financial statements of Rezeal Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Rezeal Biotech is 09AAHCR8062P1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Rezeal Biotech is U24304UP2016PTC084296. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rezeal Biotech was incorporated on 23 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Rezeal Biotech by revenue are Parchoon Desi Products Private Limited, DFB Pharma Private Limited, Mahavir Seamless Tube Private Limited, Mercyking Pharmaceuticals Private Limited, Innov Api Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Akhtar Husain was appointed as Director on 23 Jun 2016. Rehana Begum was appointed as Director on 23 Jun 2016. Seema was appointed as Director on 23 Jun 2016.
The registered office of Rezeal Biotech is at 558 A Sadar Bazar Road, Pratapgarh, Uttar Pradesh, India – 230001.
Rezeal Biotech operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Rezeal Biotech is compliant as of 22 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
